Full Event Guide
Problems Downloading?
Request your copy of the agenda here
5 Takeaways You Cannot Afford to Miss:
- Navigate developing surrogate endpoints and real-world evidence with the FDA, Bayer, and Pfizer
- Execute precision medicine approaches to targeted therapeutics with AstraZeneca, Goldfinch Bio, and University of Michigan
- Transform your translational strategy and confidently progress novel therapeutics to the clinic with Novo Nordisk, Johnson & Johnson, and Novartis
- Harness advances in innovative trial design with Chinook, GSK, National Kidney Foundation,
and Boehringer Ingelheim - Critically assess opportunities to target rare renal diseases with Sanofi, Otsuka, and Alexion